It seems you are running some fuzzy math here, absent of valuation concerns, fundamental concerns or for that matter reality issues.
No, it shouldn’t be trading at $250 per share, nor is there any reason whatsoever that it could trade that high under the current status of the company, that’s in the reality camp.
It’s trading at 4 now, but it won’t stay this low, I agree, but 250?
You claim OTC stock drop 90 percent several times because they must. You want to break that down as to the why? In fact if you don’t mind, please explain how you came up with that 250 figure.
You do understand how markets work, right?
News 
Market Data 
Discover 
